Test anxiety. Generalized anxiety disorder Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
Conditions
Interventions
Intervention 1: Intervention 1: In the experimental group, the demographic and STAI anxiety questionnaires will be completed, and the physiological parameters will be recorded before the treatment. Fi
Prevention
Placebo
Intervention 1: In the experimental group, the demographic and STAI anxiety questionnaires will be completed, and the physiological parameters will be recorded before the treatment. Fifteen minutes be
Intervention 2: In the placebo group, the demographic and the STAI anxiety questionnaires will be completed, and the physiological parameters will be recorded before the treatment. Fifteen minutes bef
Sponsors
Vice chancellor for research, Hormozgan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: The subjects should tend to participate in the study; The subjects should not have impaired sense of smell; The subjects should not have asthma and allergies to flowers, respiratory disease, heart problems, epilepsy, skin diseases, and psychological disorders; The subjects should not have used aromatherapy and other complementary medicine techniques such as progressive muscle relaxation, music therapy and the like to reduce test anxiety for a period of six weeks before their examination. And finally, the subjects should not have used anti-anxiety drugs and herbal medicines during that period. Exclusion criteria: The firm's unwillingness to continue participating in the study; The subjects showing signs of allergy to rose and lavender essential oil during the study or feeling bad during the treatment; The appearance of any physical symptoms in the subjects resulting in their inability to continue the experiment.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Test anxiety. Timepoint: Before the intervention, 15 min after the intervention, at the and of the exam. Method of measurement: Spielberger state-trait. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic BP. Timepoint: Before the intervention, 15 minutes after the intervention, at the end of the exam. Method of measurement: Manometer.;Diastolic BP. Timepoint: Before the intervention, 15 minutes after the intervention, at the end of the exam. Method of measurement: Manometer.;Pulse rate. Timepoint: Before the intervention, 15 minutes after the intervention, at the end of the exam. Method of measurement: CHronometer.;Breath rate. Timepoint: Before the intervention, 15 minutes after the intervention, at the end of the exam. Method of measurement: CHronometer, Chest movement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarges Hashemi
Faculty of nursing and midwifery
Outcome results
None listed